Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula: wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.
1. A method of making a first compound defined as:
wherein:
R 12 is OR d , or NR d R e , wherein:
R d is hydrogen; or
alkyl (C≤8) , alkenyl (C≤8) , aryl (C≤8) , heteroaryl (C≤8) , aralkyl (C≤8) , heteroaralkyl (C≤8) , or a substituted version of any of these groups;
R e is alkyl (C≤8) , alkenyl (C≤8) , aryl (C≤8) , heteroaryl (C≤8) , aralkyl (C≤8) , heteroaralkyl (C≤8) , or a substituted version of any of these groups; or
R d and R e are taken together and are -alkanediyl (C≤8) -, substituted -alkanediyl (C≤8) -, -alkenediyl (C≤8) -, substituted -alkenediyl (C≤8) -, or —N═CHCH═CH—;
wherein the first step of the synthesis comprises modification of the C-17 isocyanate group of the following compound:
2. The method of claim 1 , wherein the first compound is further defined as:
wherein:
R 12 is OR d , or NR d R e , wherein:
R d is hydrogen; or
alkyl (C≤8) , alkenyl (C≤8) , aryl (C≤8) , heteroaryl (C≤8) , aralkyl (C≤8) , heteroaralkyl (C≤8) , or a substituted version of any of these groups;
R e is alkyl (C≤8) , alkenyl (C≤8) , aryl (C≤8) , heteroaryl (C≤8) , aralkyl (C≤8) , heteroaralkyl (C≤8) , or a substituted version of any of these groups; or
R d and R e are taken together and are -alkanediyl (C≤8) -, substituted -alkanediyl (C≤8) -, -alkenediyl (C≤8) -, substituted -alkenediyl (C≤8) -, or —N═CHCH═CH—.
3. The method of claim 2 , wherein R d is hydrogen.
4. The method of claim 2 , wherein R d is alkyl (C≤8) or substituted alkyl (C≤8) .
5. The method of claim 2 , wherein R d is aryl (C≤8) or substituted aryl (C≤8) .
6. The method of claim 2 , wherein R e is alkyl (C≤8) or substituted alkyl (C≤8) .
7. The method of claim 2 , where R d and R e are taken together and are -alkanediyl (C≤8) - or substituted -alkanediyl (C≤8) -.
8. The method of claim 2 , where R d and R e are taken together and are —N═CHCH═CH—.
9. The method of claim 1 , wherein the first compound is further defined as:
wherein:
R 12 is OR d , or NR d R e , wherein:
R d is hydrogen; or
alkyl (C≤8) , alkenyl (C≤8) , aryl (C≤8) , heteroaryl (C≤8) , aralkyl (C≤8) , heteroaralkyl (C≤8) , or a substituted version of any of these groups;
R e is alkyl (C≤8) , alkenyl (C≤8) , aryl (C≤8) , heteroaryl (C≤8) , aralkyl (C≤8) , heteroaralkyl (C≤8) , or a substituted version of any of these groups; or
R d and R e are taken together and are -alkanediyl (C≤8) -, substituted -alkanediyl (C≤8) -, -alkenediyl (C≤8) -, substituted -alkenediyl (C≤8) -, or —N═CHCH═CH—.
10. The method of claim 9 , wherein R d is hydrogen.
11. The method of claim 9 , wherein R d is alkyl (C≤8) or substituted alkyl (C≤8) .
12. The method of claim 9 , wherein R d is aryl (C≤8) or substituted aryl (C≤8) .
13. The method of claim 9 , wherein R e is alkyl (C≤8) or substituted alkyl (C≤8) .
14. The method of claim 9 , where R d and R e are taken together and are -alkanediyl (C≤8) - or substituted -alkanediyl (C≤8) -.
15. The method of claim 9 , where R d and R e are taken together and are —N═CHCH═CH—.
16. The method of claim 1 , wherein the modification comprises reacting the following compound:
with a reagent of the formula HOR d , or HNR d R e , wherein:
R d is hydrogen; or
alkyl (C≤8) , alkenyl (C≤8) , aryl (C≤8) , heteroaryl (C≤8) , aralkyl (C≤8) , heteroaralkyl (C≤8) , or a substituted version of any of these groups;
R e is alkyl (C≤8) , alkenyl (C≤8) , aryl (C≤8) , heteroaryl (C≤8) , aralkyl (C≤8) , heteroaralkyl (C≤8) , or a substituted version of any of these groups; or
R d and R e are taken together and are -alkanediyl (C≤8) -, substituted -alkanediyl (C≤8) -, -alkenediyl (C≤8) -, substituted -alkenediyl (C≤8) -, or —N═CHCH═CH—.
17. The method of claim 1 , wherein the modification is conducted in the absence of a solvent (i.e. neat).
18. The method of claim 1 , wherein the modification is conducted in a medium comprising a solvent.
19. The method of claim 18 , wherein the solvent is tetrahydrofuran, benzene, or dichloromethane.
20. The method of claim 1 , wherein the modification is conducted in the presence of a base.
21. The method of claim 20 , wherein the base is NEt 3 or NaH.
22. The method of claim 1 , wherein the first compound is further defined as: